Incyclix Bio Raises $30M in Series B Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Sid Subramony News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sid Subramony. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sid Subramony Today - Breaking & Trending Today
$30 Million In New Funding Signals "Better Day to Cure Cancer" for Incyclix | North Carolina Biotechnology Center
Newly minted RTP cancer therapeutics developer Incyclix Bio has just received $30 million in Series B financing.
Source: ncbiotech.org
Incyclix Bio Raises $30M in Series B Financing
The company will use the funding to initiate a Phase I/II study of its CDK2 inhibitor in CDK4/6-resistant breast cancer and cyclin E-overexpressed ovarian cancer.
Source: precisiononcologynews.com